KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Assets: 2009-2025

Historic Assets for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $7.5 billion.

  • Charles River Laboratories International's Assets fell 6.12% to $7.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year decrease of 6.12%. This contributed to the annual value of $7.5 billion for FY2024, which is 8.13% down from last year.
  • Per Charles River Laboratories International's latest filing, its Assets stood at $7.5 billion for Q3 2025, which was down 0.62% from $7.6 billion recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Assets high stood at $8.2 billion for Q4 2023, and its period low was $5.8 billion during Q1 2021.
  • For the 3-year period, Charles River Laboratories International's Assets averaged around $7.8 billion, with its median value being $7.7 billion (2023).
  • In the last 5 years, Charles River Laboratories International's Assets surged by 35.39% in 2021 and then decreased by 8.13% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Assets (Quarterly) stood at $7.0 billion in 2021, then increased by 8.24% to $7.6 billion in 2022, then grew by 7.79% to $8.2 billion in 2023, then decreased by 8.13% to $7.5 billion in 2024, then decreased by 6.12% to $7.5 billion in 2025.
  • Its last three reported values are $7.5 billion in Q3 2025, $7.6 billion for Q2 2025, and $7.6 billion during Q1 2025.